Anti-TEX14 monoclonal antibody

Pre-made anti-TEX14 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TEX14/TEX14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2768-Ab-1/ GM-Tg-hg-IP2768-Ab-2Anti-Human TEX14 monoclonal antibodyHuman
GM-Tg-rg-IP2768-Ab-1/ GM-Tg-rg-IP2768-Ab-2Anti-Rat TEX14 monoclonal antibodyRat
GM-Tg-mg-IP2768-Ab-1/ GM-Tg-mg-IP2768-Ab-2Anti-Mouse TEX14 monoclonal antibodyMouse
GM-Tg-cynog-IP2768-Ab-1/ GM-Tg-cynog-IP2768-Ab-2Anti-Cynomolgus/ Rhesus macaque TEX14 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2768-Ab-1/ GM-Tg-felg-IP2768-Ab-2Anti-Feline TEX14 monoclonal antibodyFeline
GM-Tg-cang-IP2768-Ab-1/ GM-Tg-cang-IP2768-Ab-2Anti-Canine TEX14 monoclonal antibodyCanine
GM-Tg-bovg-IP2768-Ab-1/ GM-Tg-bovg-IP2768-Ab-2Anti-Bovine TEX14 monoclonal antibodyBovine
GM-Tg-equg-IP2768-Ab-1/ GM-Tg-equg-IP2768-Ab-2Anti-Equine TEX14 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2768-Ab-1/ GM-Tg-hg-IP2768-Ab-2; GM-Tg-rg-IP2768-Ab-1/ GM-Tg-rg-IP2768-Ab-2;
GM-Tg-mg-IP2768-Ab-1/ GM-Tg-mg-IP2768-Ab-2; GM-Tg-cynog-IP2768-Ab-1/ GM-Tg-cynog-IP2768-Ab-2;
GM-Tg-felg-IP2768-Ab-1/ GM-Tg-felg-IP2768-Ab-2; GM-Tg-cang-IP2768-Ab-1/ GM-Tg-cang-IP2768-Ab-2;
GM-Tg-bovg-IP2768-Ab-1/ GM-Tg-bovg-IP2768-Ab-2; GM-Tg-equg-IP2768-Ab-1/ GM-Tg-equg-IP2768-Ab-2
Products NameAnti-TEX14 monoclonal antibody
Formatmab
Target NameTEX14
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TEX14 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2768-Ag-1Recombinant multi-species TEX14/ CT113/ SPGF23 protein


    Target information

    Target IDGM-IP2768
    Target NameTEX14
    Gene ID56155,83560,287603,714776,480572,101096273,522810,100057035
    Gene Symbol and SynonymsCT113,SPGF23,TEX14
    Uniprot AccessionQ8IWB6,F1M5M3,F1MJR8
    Uniprot Entry NameTEX14_HUMAN,TEX14_RAT,TEX14_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000121101
    Target ClassificationN/A

    The target: TEX14, gene name: TEX14, also named as CT113, SPGF23. The protein encoded by this gene is necessary for intercellular bridges in germ cells, which are required for spermatogenesis. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.